Inhaled corticosteroids in children with persistent asthma: Dose-response effects on growth

Evidence-Based Child Health

Volumn 9, Issue 4, 2014, Pages 931-1046

  Pruteanu, Aniela I ^a   Chauhan, Bhupendrasinh F ^a   Zhang, Linjie ^b   Prietsch, Sílvio Om ^b   Ducharme, Francine M ^a,c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; HYDROCORTISONE; MOMETASONE FUROATE; PLACEBO; SALMETEROL; THEOPHYLLINE;

ARTICLE; ASTHMA; BODY HEIGHT; BODY MASS; CELL MATURATION; CHILD; CHILD GROWTH; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; DRY POWDER INHALER; EVENING DOSAGE; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; GROWTH INHIBITION; GROWTH RATE; HUMAN; HYDROCORTISONE URINE LEVEL; INHALER; INTENTION TO TREAT ANALYSIS; LOW DRUG DOSE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; METERED DOSE INHALER; NEBULIZER; PERSISTENT ASTHMA; PERSISTENT INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEXUAL MATURITY; SKELETAL MUSCLE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

EID: 84916596776     PISSN: 20404050     EISSN: 15576272     Source Type: Journal    
DOI: 10.1002/ebch.1989     Document Type: Article

References (138)

1. Allen DB, Bronsky EA, LaForce CF, Nathan RA, Tinkelman D, Vandewalker ML, et al.Growth in asthmatic children treated with fluticasone propionate. Journal of Pediatrics 1998;132(3 I):472-7.
2. Baker J, Mellon M, Wald J, Welch M, Cruz-Rivera M. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics 1999;103(2):414-21.
3. Baker J, Mellon M, Wald J, Welch M, Cruz-Rivera M. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics 1999;103(2):414-421.
4. Brand PL, Luz Garcia-Garcia M, Morison A, Vermeulen JH, Weber HC. Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respiratory Medicine 2011;105(11):1588-95.
5. Brand PL, Luz Garcia-Garcia M, Morison A, Vermeulen JH, Weber HC. Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. Respiratory Medicine 2011/11;105(11):1588-95.
6. Chen A, Chen R, Zhong N. Systemic side effects of long-term treatment with low dose inhaled corticosteroids in children with asthma. Chinese Journal of Tuberculosis and Respiratory Diseases 2001;24(12):740-3.
7. Doniec Z, Pierzchala-Koziec K, Tomalak W, Nowak D, Kurzawa R. Powder budesonide decreases plasma level of native and cryptic met-enkephalin in asthmatic children. International Review of Allergology and Clinical Immunology 2004;10(3):105-9.
8. Gelfand EW, Georgitis JW, Noonan M, Ruff ME. Once-daily ciclesonide in children: efficacy and safety in asthma. Journal of Pediatrics 2006;148(3):377-83.
9. Gelfand EW, Georgitis JW, Noonan M, Ruff ME. Once-daily ciclesonide in children: efficacy and safety in asthma. J Pediatrics 2006;148(3):377-83.
10. Giorgi PL, Oggiano N, Kantar A, Coppa GV, Ricciotti R, Arena F, et al.Bone metabolism in children with asthma treated with nebulized flunisolide: a multicenter Italian study. Current Therapeutic Research, Clinical and Experimental 1998;59(12):896-908.
11. Jónasson G, Carlsen K-H, Blomqvist P. Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids. European Respiratory Journal 1998;12:1099-104.
12. Jonasson G, Carlsen KH, Jonasson C, Mowinckel P. Low-dose inhaled budesonide once or twice daily for 27 months in children with mild asthma. Allergy 2000;55(8):740-8.
13. Kemp JP, Skoner DP, Szefler SJ, Walton-Bowen K, Cruz-Rivera M, Smith JA. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. Annals of Allergy 1999;83(3):231-9.
14. Kemp JP, Skoner DP, Szefler SJ, Walton-Bowen K, Cruz-Rivera M. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. Annals of Allergy 1999;83(3):231-9.
15. Kerwin EM, Pearlman DS, de Guia T, Carlsson LG, Gillen M, Uryniak T, et al.Evaluation of efficacy and safety of budesonide delivered via two dry powder inhalers. Current Medical Research and Opinion 2008;24(5):1497-510.
16. Kerwin EM, Pearlman DS, de Guia T, Carlsson LG, Gillen M, Uryniak T. Evaluation of efficacy and safety of budesonide delivered via two dry powder inhalers. Current Medical Research and Opinion 2008;24(5):1497-510.
17. Lemanske RF, Lockey RF, Murphy KR. Effects of one year of treatment with mometasone furoate metered dose inhaler (MF-MDI) on growth in children with asthma. European Respiratory Journal 2004;24(Suppl 48):379s.
18. Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. Journal of Allergy & Clinical Immunology 1998;102(1):32-8.
19. Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. Journal of Allergy & Clinical Immunology 1998;102(1):32-8.
20. Pedersen S, Potter P, Dachev S, Bosheva M, Kaczmarek J, Springer E, et al.Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the rainbow study. Respiratory Medicine 2010;104(11):1618-28.
21. Pedersen S, Potter P, Dachev S, Bosheva M, Kaczmarek J, Springer E, et al.Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the rainbow study. Respiratory Medicine 2010;104(11):1618-28.
22. Shapiro G, Bronsky EA, LaForce CF, Mendelson L, Pearlman D, Schwartz RH, et al.Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. Journal of Pediatrics 1998;132(6):976-82.
23. Shapiro G, Bronsky EA, LaForce CF, Mendelson L, Pearlman D, Schwartz RH. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics 1998;132(6):976-82.
24. Shapiro G, Bronsky EA, LaForce CF, Mendelson L, Pearlman D, Schwartz RH. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics 1998;132(6):976-82.
25. Shapiro G, Bronsky EA, LaForce CF, Mendelson L, Pearlman D, Schwartz RH. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatrics 1998;132(6):976-82.
26. Skoner DP, Maspero J, Banerji D. Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics 2008;121(1):e1-14.
27. Skoner DP, Meltzer EO, Milgrom HA, Stryszak P, Teper A, Staudinger H. Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma. Journal of Asthma 2011;48(8):848-59.
28. Skoner DP, Meltzer EO, Milgrom HA, Stryszak P, Teper A, Staudinger H. Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma. Journal of Asthma 2011;48(8):848-59.
29. Sorkness CA, Lemanske RF Jr, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, et al.Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. Journal of Allergy and Clinical Immunology 2007;119(1):64-72.
30. Teper AM, Colom AJ, Kofman CD, Maffey AF, Vidaurreta SM, Bergada I. Effects of inhaled fluticasone propionate in children less than 2 years old with recurrent wheezing. Pediatric Pulmonology 2004;37(2):111-5.
31. Vaessen-Verberne AA, van den Berg NJ, van Nierop JC, Brackel HJ, Gerrits GP, Hop WC, et al.Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma. American Journal of Respiratory and Critical Care Medicine 2010;182(10):1221-7.
32. Verberne AA, Frost C, Duiverman EJ, Grol MH, Kerrebijn KF. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. American Journal of Respiratory and Critical Care Medicine 1998;158(1):213-9.
33. Verberne AA, Frost C, Duiverman EJ, Grol MH, Kerrebijn KF. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. American Journal of Respiratory and Critical Care Medicine 1998;158(1):213-9.
34. Wasserman RL, Baker JW, Kim KT, Blake KV, Scott CA, Wu W, et al.Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study. Annals of Allergy, Asthma, and Immunology 2006;96(6):808-18.
35. Agertoft L, Pedersen S. Inhaled ciclesonide does not effect lower leg growth rate or HPA-axis function in children with mild asthma. European Respiratory Journal 2004;24(Suppl 48):377s.
36. Antoniu SA. The START study: when to start to treat with inhaled steroids in asthma?. Expert Review of Pharmacoeconomics & Outcomes Research 2003;3(3):223-5.
37. Apold J, Djoseland O. Inhaled beclomethasone dipropionate in the treatment of childhood asthma. Postgraduate Medical Journal 1975;51(Suppl 4):104-5.
38. Asrilant M. Beclomethasone dipropionate: an aerosol corticosteroid for topical use in bronchial asthma. Postgraduate Medical Journal 1975;51(Suppl 4):79-83.
39. Bateman ED, Cheung D, Lapa e Silva J, Gohring UM, Schafer M, Engelstatter R. Randomized comparison of ciclesonide 160 and 640 mug/day in severe asthma. Pulmonary Pharmacology and Therapeutics 2008;21(3):489-98.
40. Baxter-Jones AD, Helms PJ. Effect of 6 month daily treatment with inhaled corticosteroids on lower leg growth in pre-school wheezing children: a pragmatic trial. Thorax 1998;53(Suppl 4):A5 S19.
41. Berger WE, Qaqundah PY, Blake K, Rodriguez-Santana J, Irani AM, Xu J, et al.Safety of budesonide inhalation suspension in infants aged six to twelve months with mild to moderate persistent asthma or recurrent wheeze. The Journal of Pediatrics 2005;146(1):91-5.
42. Bernstein DI, Berkowitz RB, Chervinsky P, Dvorin DJ, Finn AF, Gross GN, et al.Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler. Respiratory Medicine 1999;93(9):603-12.
43. Birkebaek NH, Esberg G, Andersen K, Wolthers O, Hassager C. Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate. Archives of Disease in Childhood 1995;73(6):524-7.
44. Breborowicz A, Niedziela M. Low risk of adrenal dysfunction in children with severe asthma treated with high dose inhaled glucocorticoids. European Respiratory Journal 2005;26(Suppl 49SP):Abstract No. 1058.
45. Brook CG. Short stature never killed anybody. Journal of Pediatrics 1998;133(5):591-2.
46. Brown HM, Storey G. Beclomethasone dipropionate steroid aerosol in treatment of perennial allergic asthma in children. British Medical Journal 1973;3(872):161-4.
47. Chuchalin A, Jacques L, Frith L. Salmeterol/fluticasone propionate via Diskus[trademark] once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids. Clinical Drug Investigation 2008;28(3):169-81.
48. Dickson W, Hall CE, Ellis M, Horrocks RH. Beclomethasone dipropionate aerosol in childhood asthma. Archives of Disease in Childhood 1973;48(9):671-5.
49. Ferguson AC, Van Bever HP, Teper AM, Lasytsya OI, Whitehead PJ. Fluticasone propionate 100μg bd (FP100) has significantly less effect than budesonide 200μg bd (BUD200) on childhood growth over 1 year of treatment in asthmatics. European Respiratory Journal 2002;20(Suppl 38):219s.
50. Godfrey S, Konig P. Beclomethasone aerosol in childhood asthma. Archives of Disease in Childhood 1973;48(9):665-70.
51. Godfrey S, Konig P. Treatment of childhood asthma for 13 months and longer with beclomethasone dipropionate aerosol. Archives of Disease in Childhood 1974;49(8):591-6.
52. Guarnaccia S, Buzi F, LaGrutta S, Marini S, Laffranchi MG, Brunori A, et al.High dose inhaled corticosteroids (IC) in children with asthma: influence on bone metabolism. European Respiratory Journal 1996;9(Suppl 23):295s.
53. Guo JG, Cheng ST. The efficacy of low-dose oral aminophylline combined with inhaled corticosteroid in the treatment of asthmatic children in remission period. Acta Academic Medicine Xuzhou 2002;22(4):349-51.
54. Gwynn CM, Smith JM. Long-term results with beclomethasone dipropionate aerosol in children with bronchial asthma: why does it sometimes fail?. British Journal of Clinical Pharmacology 1977;4(Suppl 3):269S-271S.
55. Hansel TT, Benezet O, Kafe H, Ponitz HH, Cheung D, Engelstatter R, et al.A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma. Clinical Therapeutics 2006;28(6):906-20.
56. Kaiser H, Parasuraman B, Boggs R, Miller CJ, Leidy NK, O'Dowd L. Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids. Annals of Allergy, Asthma, and Immunology 2008;101(3):295-303.
57. Karpel JP, Nayak A, Lumry W, Craig TJ, Kerwin E, Fish JE, et al.Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma. Respiratory Medicine 2007;101(3):628-37.
58. Kemp JP, Osur S, Shrewsbury SB, Herje NE, Duke SP, Harding SM, et al.Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial. Mayo Clinic Proceedings 2004;79(4):458-66.
59. Lang JE, Dozor AJ, Holbrook JT, Mougey E, Krishnan S, Sweeten S, et al.Biologic mechanisms of environmental tobacco smoke in children with poorly controlled asthma: results from a multicenter clinical trial. Journal of Allergy and Clinical Immunology: In Practice 2013;1(2):172-180.e2.
60. Laursen LC, Taudorf E, Weeke B. High-dose inhaled budesonide in treatment of severe steroid-dependent asthma. European Journal of Respiratory Diseases 1986;68(1):19-28.
61. Lipworth BJ, Clark D. High-dose inhaled steroids in asthmatic children. Lancet 1996;348(9030):820; discussion 821.
62. Lovera J, Collins-Williams C, Bailey J. Beclomethasone dipropionate by aerosol in the treatment in asthmatic children. Postgraduate Medical Journal 1975;51(Suppl 4):96-8.
63. McAllen MK, Kochanowski SJ, Shaw KM. Steroid aerosols in asthma: an assessment of betamethasone valerate and a 12-month study of patients on maintenance treatment. British Medical Journal 1974;1(900):171-5.
64. Neffen H, Ruff M, Zhang P, Lloyd M, Banjeri D. Ciclesonide administered once daily has no effect on skeletal maturity in prepubertal children with mild persistent asthma [Abstract]. Journal of Allergy and Clinical Immunology 2006;117(2):184.
65. Nelson HS, Kane RE, Petillo J, Banerji D, Anolik R, Bosso J, et al.Long-term safety of a non-chlorofluorocarbon-containing triamcinolone acetonide inhalation aerosol in patients with asthma. Journal of Asthma 2000;37(2):145-52.
66. Niu CK, Huang SC, Huang CB. Effect of short-course budesonide on the bone turnover of asthmatic children. Pediatric Pulmonology 1998;26(4):290-2.
67. Otsuki M, Eakin MN, Rand CS, Butz AM, Hsu VD, Zuckerman IH, et al.Adherence feedback to improve asthma outcomes among inner-city children: a randomized trial. Pediatrics 2009;124(6):1513-21.
68. Pearlman DS, Berger WE, Kerwin E, LaForce C, Kundu S, Banerji D. Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma. Journal of Allergy and Clinical Immunology 2005;116(6):1206-12.
69. Pedeersen S, Agertoft L, Lee T, Staudinger H. Lower-leg growth in children with asthma during treatment with inhaled corticosteroids. Journal of Allergy and Clinical Immunology 2003;111(2 Suppl):S269.
70. Pedersen S, Warner J, Wahn U, Staab D, Le Bourgeois M, Van Essen-Zandvliet E, et al.Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children. Pediatrics 2002;109(6):e92.
71. Peroni DG, Piacentini GL, Bodini A, Ress M, Costella S, Boner AL. Montelukast versus formoterol as second-line therapy in asthmatic children exposed to relevant allergens. Allergy and Asthma Proceedings 2005;26(4):283-6.
72. Phipatanakul W, Greene C, Downes SJ, Cronin B, Eller TJ, Schneider LC, et al.Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids. Annals of Allergy, Asthma, and Immunology 2003;91(1):49-54.
73. Pines A. Beclomethasone dipropionate used as an aerosol in the treatment of asthma. Practitioner 1973;211(261):86-90.
74. Skoner DP, Szefler SJ, Welch M, Walton-Bowen K, Cruz-Rivera M, Smith JA. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma. Journal of Allergy and Clinical Immunology 2000;105(2 Pt 1):259-68.
75. Skoner D, Maspero J, Kundu S, Lloyd M, Banerji D. Ciclesonide administered once daily has no effect on growth velocity in prepubertal children with mild persistent asthma. Journal of Allergy and Clinical Immunology 2006;117(2 Suppl 1):S11.
76. Skoner DP, Gentile DA, Angelini B. Effect of therapeutic doses of mometasone furoate on cortisol levels in children with mild asthma. Allergy and Asthma Proceedings 2010;31(1):10-19.
77. Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, et al.Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008;372(9643):1065-72.
78. Thompson PJ, Davies RJ, Young WF, Grossman AB, Donnell D. Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol. Respiratory Medicine 1998;92(Suppl A):33-9.
79. Turpeinen M, Nikander K, Pelkonen AS, Syvänen P, Sorva R, Raitio H, et al.Daily versus as-needed inhaled corticosteroid for mild persistent asthma (the Helsinki early intervention childhood asthma study). Archives of Disease in Childhood 2008;93(8):654-9.
80. Visser MJ, Postma DS, Arends LR, de Vries TW, Duiverman EJ, Brand PL. One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma. Effects on hyperresponsiveness, lung function, and height. American Journal of Respiratory and Critical Care Medicine 2001;164(11):2073-7.
81. Visser MJ, Duiverman EJ, Postma DS, Arends LR, Brand PLP. High doses of inhaled fluticasone propionate dose-dependently suppress adrenal cortical function in asthmatic children. European Respiratory Journal 2001;18(Suppl 33):290s.
82. Visser MJ, van der Veer E, Postma DS, Arends LR, de Vries TW, Brand PLP, et al.Side-effects of fluticasone in asthmatic children: no effects after dose reduction. European Respiratory Journal 2004;24(3):420-5.
83. Wasserman SI, Gross GN, Schoenwetter WF, Munk ZM, Kral KM, Schaberg A, et al.A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma. Journal of Asthma 1996;33(4):265-74.
84. Wasserman SI, Gross GN, Schoenwetter WF, Munk ZM, Kral KM, Schaberg A, et al.A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma. Journal of Asthma 1996;33(4):265-74.
85. Waugh J, Goa KL. Flunisolide HFA. American Journal of Respiratory Medicine 2002;1(5):369-72; discussion 373.
86. Williams LK, Peterson EL, Wells K, Campbell J, Wang M, Chowdhry VK, et al.A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. Journal of Allergy and Clinical Immunology 2010;126(2):225-231, 231.e1-4.
87. Wolthers OD, Juul A, Hansen M, Muller J, Pedersen S. The insulin-like growth factor axis and collagen turnover in asthmatic children treated with inhaled budesonide. Acta Paediatrica 1995;84:393-7.
88. Xu Z, Chen H-Y, Zhang S-Y, Wang X-L, He C-R, Qiao Y-X. Efficacy and safety of corticosteroid inhalation in the treatment of childhood asthma. Zhongguo Dangdai Erke Zazhi 2005;7(1):47-50.
89. Adams NP, Bestall JC, Lasserson TJ, Jones P, Cates CJ. Fluticasone versus placebo for chronic asthma in adults and children. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD003135.pub4]
90. Adams NP, Bestall JB, Malouf R, Lasserson TJ, Jones PW. Inhaled beclomethasone versus placebo for chronic asthma. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD002738.pub2]
91. Adams NP, Bestall JB, Jones PW. Budesonide versus placebo for chronic asthma in children and adults. Cochrane Database of Systematic Reviews 1999, Issue 4. [DOI: 10.1002/14651858.CD003274]
92. Agertoft L, Laulund LW, Harrison LI, Pedersen S. Influence of particle size on lung deposition and pharmacokinetics of beclomethasone dipropionatein children. Pediatric Pulmonology 2003;35:192-9.
93. Agertoft L, Pedersen S. Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children. American Journal of Respiratory and Critical Care Medicine 2003;168:779-82.
94. Allen DB. Limitations of short-term studies in predicting long-term adverse effects of inhaled corticosteroids. Allergy 1999;54:29-34.
95. Allen DB. Safety of inhaled corticosteroids in children. Pediatric Pulmonology 2002;33:208-20.
96. Allen DB. Effects of inhaled steroids on growth, bone metabolism, and adrenal function. Advances in Pediatrics 2006;53:101-10.
97. Asher MI. Recent perspectives on global epidemiology of asthma in childhood. Allergologia et Immunopathologia (Madrid) 2010;38(2):83-7.
98. Barnes PJ, Adcock IM. How do corticosteroids work in asthma?. Annals of Internal Medicine 2003;139:359-70.
99. Braman SS. The global burden of asthma. Chest 2006;130:4S-12S.
100. Brand PLP. Inhaled corticosteroids reduce growth. Or do they?. European Respiratory Journal 2001;17:287-94.
101. British Thoracic Society and Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. A national clinical guideline. May 2008 (revised January 2012). http://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&ved=0CDYQFjAA&url=http%3A%2F%2Fwww.sign.ac.uk%2Fpdf%2Fsign101.pdf&ei=qN_nUY3DPIem4gTc6IDoBQ&usg=AFQjCNFZSipqqDue5MN9iBKrWV1MoM4gxg&sig2=K4MXf4g8R4xKCs45kBiI-g&bvm=bv.49478099, d.bGE (accessed 20 June 2012).
102. Szefler S, Weiss S, Tonascia J. Long-term effects of budesonide or nedocromil in children with asthma. The New England Journal of Medecine 2000;343:1054-63.
103. Kelly HW, Sternberg AL, Lescher R, Fuhlbrigge AL, Williams P, Zeiger RS. Effect of inhaled glucocorticoids in childhood on adult height. The New England Journal of Medecine 2012;367:904-12.
104. Carlsen KH, Gerritsen J. Inhaled steroids in children: adrenal suppression and growth impairment. European Respiratory Journal 2002;19:985-8.
105. Chauhan BF, Ducharme FM. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database of Systematic Reviews 2012, Issue 5. [DOI: 10.1002/14651858.CD002314.pub3]
106. Covar RA, Szefler SJ, Martin RJ, Sundstrom DA, Silkoff PE, Murphy J, et al.Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. Journal of Pediatrics 2003;142(5):469-75.
107. Creese KH, Doull IJ. Effects of inhaled corticosteroids on growth in asthmatic children. Current Allergy and Asthma Reports 2001;1(2):122-6.
108. Efthimiou J, Barnes PJ. Effect of inhaled corticosteroids on bones and growth. European Respiratory Journal 1998;11:1167-77.
109. US Food, Drug Administration (FDA). FDA requires new pediatric labelling for inhaled, intranasal corticosteroids. FDA Talk Paper. November 9, 1998.
110. Global Initiative for Asthma (GINA). From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014. http://www.ginasthma.org/local/uploads/files/GINA_Report_2014.pdf 2014.
111. Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ. Long-term inhaled corticosteroids in preschool children at high risk for asthma. The New England Journal of Medecine 2006;354:1985-97.
112. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration. www.cochrane-handbook.org, 2008.
113. ISAAC Steering Committee. Worldwide variations in the prevalence of asthma symptoms: the International Studyof Asthma and Allergies in Childhood (ISAAC). European Respiratory Journal 1998;12:315-35.
114. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. American Review of Respiratory Disease 1990;142(4):832-6.
115. Lai C, Beasley R, Crane J, Foliaki S, Shah J, Weiland S. Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009;64(6):476-83.
116. Lougheed MD, Lemiere C, Ducharme FM, Licskai C, Del SD, Rowe BH, et al.Canadian Thoracic Society 2012 guideline update. Diagnosis and management of asthma in preschoolers, children and adults. Canadian Respiratory Journal 2012;19(2):127-64.
117. Martin RJ, Szefler SJ, Chinchilli VM, Kraft M, Dolovich M, Boushey HA, et al.Systemic effect comparisons of six inhaled corticosteroid preparations. American Journal of Respiratory and Critical Care Medicine 2002;165:1377-83.
118. Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59(5):469-78.
119. National Heart Lung and Blood Institute. Guidelines for the diagnosis and management of asthma (EPR-3). http://www.nhlbi.nih.gov/guidelines/asthma/ (accessed 20 June 2011).
120. Expert Panel Report 2007. Guidelines for the Diagnosis and Management of Asthma [National Heart, Lung and Blood Institute, National Institute of Health]. www.nhlbi.nih.gov.clinical practice guidelines (accessed 10 December 2012).
121. Olivieri D, Chetta A, Del Donno M, Bertorelli G, Casalini A, Pesci A, et al.Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. American Journal of Respiratory and Critical Care Medicine 1997;155(6):1864-71.
122. Pedersen S. Do inhaled corticosteroids inhibit growth in children?. Americian Journal of Respiratory and Critical Care Medicine 2001;164(4):521-35.
123. Price J, Hindmarsh P, Hughes S, Efthimiou J. Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature?. European Respiratory Journal 2002;19:1179-93.
124. Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration. Review Manager (RevMan) Version 5.0. Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration, 2008.
125. Salvatoni A, Piantanida E, Nosetti L, Nespoli L. Inhaled corticosteroids in childhood asthma: long-term effects on growth and adrenocortical function. Paediatric Drugs 2003;5(6):351-61.
126. Sharek PJ, Bergman D, Francine D. Beclomethasone for asthma in children: effects on linear growth. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD001282]
127. Sharek PJ, Bergman DA. The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis. Pediatrics 2000;106:e8.
128. Simons FER and Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. The New England Journal of Medicine 1997;337:1659-65.
129. Sinonenko PC. Effects of inhaled or nasal glucocorticosteroids on adrenal function and growth. Journal of Pediatric Endocrinology and Metabolism 2002;15(1):5-26.
130. Skoner DP, Meltzer EO, Milgrom H, Stryszak P, Teper A, Staudinger H. Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma. The Journal of Asthma 2011;48:848-59.
131. Sobande PO, Kercsmar CM. Inhaled corticosteroids in asthma management. Respiratory Care 2008;53(5):625-33.
132. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. New England Journal of Medicine 2000;343(5):332-6.
133. Guidance for industry orally inhaled and intranasal corticosteroids: evaluation of the effects on growth in children, 2007. http://www.fda.gov/cder/guidance/index.htm.
134. Van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. American Review of Respiratory Disease 1992;146(3):547-54.
135. Van Rensen EL, Straathof KC, Veselic-Charvat MA, Zwinderman AH, Bel EH, Sterk PJ. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax 1999;54(5):403-8.
136. Witzmann KB, Fink RJ. Inhaled corticosteroids in childhood asthma: growing concerns. Drugs 2000;59(Suppl 1):9-14.
137. Wolthers O, Hansen M, Juul A, Nielsen HK, Pedersen S. Knemometry, urine cortisol excretion and measures of the insulin-like growth factor axis and collagen turnover in the assessment of systemic activity of inhaled corticosteroids in children with persistent asthma: effects on growth. Pediatric Research 1997;41:44-50.
138. Zhang L, Axelsson I, Prietsch SOM. Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database of Systematic Reviews 2011, Issue 12. [DOI: 10.1002/14651858.CD009471]